Article updated in May 2020 adding new resources and studies to the article
A study conducted by researchers at the Roskamp Institute in Florida, and published in the journal Molecular and Cellular Neuroscience, has found that cannabis can slow the effects of Alzheimer’s Disease, and may in fact be able to halt it entirely.
According to Corbin Bachmeier, Ph.D – who’s the lead researcher of the study – Alzheimer’s Disease is “the result of impaired Aβ [Amyloid-β protein] clearance from the brain”. According to this study, cannabis can solve this problem, making it a potential treatment.
PatientsAccording to a new study, access to cannabis reduces pain patients’ perceived demand for opioids. The study, published in the Journal of Psychopharmacology, is titled Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasks. It was first reported on by the National Organization for the Reformation of Marijuana Laws (NORML).
For the study researchers from John Hopkins School of Medicine examined whether or not cannabis availability would hypothetically influence pain patients’ demand for prescription opioids. 155 subjects with recent experience using both opioids and cannabis for pain management participated in the survey.
According to a new study, those who use marijuana for therapeutic purposes are more likely to report consuming it to address symptoms such as anxiety, insomnia, chronic pain and depression. The study, titled Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population,” was published in the Journal of General Internal Medicine and first reported on by NORML.
For the study researchers examined responses from a nationally represented online sample of adults. “Among those who acknowledged using cannabis for medical purposes, 49 percent reported doing so to treat anxiety. Forty-seven percent of respondents said that they used cannabis for insomnia, 42 percent said that they did so to treat chronic pain, and 39 percent said that cannabis eased their depression.”
A new study has “confirmed that the therapeutic benefit of cannabinoids may extend beyond spasticity, improving spasticity-related symptoms even in non-NRS responder patients”. The study, titled Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study, was published in the journal Neurological Sciences
According to a newly released study that will come as no surprise to marijuana consumers and advocates, cannabis is completely “distrinct from tobacco” in that it is not associated with either lung cancer, or Chronic Obstructive Pulmonary Disease (COPD). The study, titled Cannabis use disorder and the lungs, was published in the most recent issue of the journal Addiction. Prior to this it was epublished ahead of print by the U.S. National Institute of Health.
According to a new study first reported on by NORML and published in the journal Discoveries, the daily administration of whole-plant cannabis oil is associated with a significant improvement in symptoms of anxiety and vertigo.
For the case report an Australian investigator reported on the successful use of cannabis oil for symptom management in an 88-year-old female patient with generalized anxiety disorder and debilitating vertigo. The patient reported “significant improvements in her quality of life” following four weeks of daily cannabis use (2 ml of THC-dominant oil). The subject reported that her nausea, dizziness, and limited mobility returned shortly after she stopped taking cannabis oil. Symptoms ceased when she once again reintegrated cannabis oil into her daily treatment regimen.
According to a new study, men who report having consumed marijuana in the past year possess elevated levels of testosterone as compared to non-users. The study, titled The effect of tetrahydrocannabinol on testosterone among men in the United States: Results from the National Health and Nutrition Examination Survey, was published in the World Journal of Urology.
Those with spinal cord injuries may find their symptoms eased by cannabinoids – the compounds found in cannabis – according to a new study. The study, titled The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord, is being published in the upcoming issue of the journal Current Neuropharmacology – it was epublished ahead of print online by the National Institute of Health.
The oral administration of purified CBD is associated with anxiolytic and anti-psychotic activity while possessing few adverts side-effects. This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. National Institute of Health.
For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. They found that “There is some evidence that supports anxiolytic effect of acute administration of oral CBD. There is moderate-quality evidence that chronic and acute administration of CBD can improve psychotic symptoms in schizophrenia patients.”
According to a new study in the Journal of Clinic Medicine, the use of Tetrahydrocannabinol (THC) could have adverse drug effects when combined with other medications due to drug-drug interactions. April 18, 2020 Update –> Map originally used was outdated.
Cannabis Sativa, a.k.a “marijuana” is the one of the most popular illicit substances in the world. Its psychoactive ingredient, THC, has made cannabis a highly used recreational drug for millennia.
Over the past few decades, there has been an increased interest in leveraging cannabis and cannabinoids for medicinal purpose. And with the legalization of cannabis in Canada and legislation in 33 US states allowing for some kind of marijuana use (recreational or medicinal), the popularity of cannabis has been on the rise.
There is a strong belief that the plant is relatively benign because of the amount of recreational use in the younger generations. But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications.
This study summarizes potential adverse drug events related to THC when combined with other medications